Abstracts tagged "polymyositis/dermatomyositis (PM/DM) and rituximab"

Abstract Number: 211 • ACR/ARHP Annual Meeting 2012
Efficacy and Safety of Disease Modifying Drugs, Biologic Therapies and Immunoglobulin in Patients with Polymyositis and Dermatomyositis: A Systematic Literature Review
JA Martinez-Lopez Sr.¹, J. Graña Sr.², Santiago Muñoz-Fernandez³, I. Rua-Figueroa⁴, José M. Pego-Reigosa⁵, Estíbaliz Loza Sr.⁶ and SER group for the study of systemic autoimmune diseases⁷, ¹Fundacion Jimenez Diaz, Madrid, Spain, ²Hospital Juan Canalejo, Spain, ³Unit Rheumatology, Hospital Infanta Sofía, Madrid, Spain, ⁴Rheumatology, Hospital de GC Dr Negrin, Las Palmas GC, Spain, ⁵Rheumatology, Hospital do Meixoeiro, Vigo, Spain, ⁶Research Unit. Sociedad Española de Reumatología, Madrid, Spain, ⁷Madrid
Background/Purpose: The aim of this study was to systematically review the efficacy and safety of available drugs in patients with polymyositis (PM) or dermatomyositis (DM)Methods:…
Abstract Number: 220 • ACR/ARHP Annual Meeting 2012
Efficacy of Rituximab for the Treatment of Refractory Inflammatory Myopathies Associated with Anti-Histidyl-tRNA Synthetase Antibodies (the FORCE Jo1 Study)
Yves Allenbach¹, Aude Rigolet², Marguerite Guiguet³, Isabelle Marie⁴, Eric Hachulla⁵, Dominique Farge⁶, Kuberaka Mariampillai⁷, Serge Jacquot⁸, Fabienne Jouen⁹, Olivier Boyer¹⁰, Lucile Musset¹¹, Serge Herson⁷ and Olivier Benveniste¹², ¹Internal Medicine Dpt 1, Pitié-Salpêtrière Hospital, APHP, Paris, France, ²Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France, ³Biostatistique, Pitie-Salpetriere Hospital, Paris, France, ⁴Service de médecine interne, CHU de Rouen, Rouen, France., Rouen, France, ⁵Department of Internal Medicine, Claude Huriez University Hospital, Lille, France, ⁶Medicine, EBMT, Paris, France, ⁷Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University, Paris, France, ⁸INSERM U905, University of Rouen, Rouen, France, ⁹Immunology, Rouen University Hospital, Rouen Cedex, France, ¹⁰Immunology, INSERM U905, University of Rouen, Rouen, France, ¹¹Laboratoire d'Immunochimie, CHU Pitié-Salpêtrière, Paris, France, ¹²Internal Medecine Dpt 1, Pitié-Salpêtrière Hospital, APHP, Paris, France
Background/Purpose: anti-histidyl-tRNA synthetase (anti-Jo1) antibodies are found in approximately 25–30% of patients with idiopathic inflammatory myopathies, frequently in the frame of an anti-synthetase syndrome characterized…